These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 29175274)
1. Provision of menstrual regulation with medication among pharmacies in three municipal districts of Bangladesh: a situation analysis. Huda FA; Mahmood HR; Alam A; Ahmmed F; Karim F; Sarker BK; Al Haque N; Ahmed A Contraception; 2018 Feb; 97(2):144-151. PubMed ID: 29175274 [TBL] [Abstract][Full Text] [Related]
2. Feasibility of assessing the safety and effectiveness of menstrual regulation medications purchased from pharmacies in Bangladesh: a prospective cohort study. Footman K; Scott R; Taleb F; Dijkerman S; Nuremowla S; Reiss K; Church K Contraception; 2018 Feb; 97(2):152-159. PubMed ID: 28823841 [TBL] [Abstract][Full Text] [Related]
3. Availability and provision of misoprostol and other medicines for menstrual regulation among pharmacies in Bangladesh via mystery client survey. Huda FA; Ngo TD; Ahmed A; Alam A; Reichenbach L Int J Gynaecol Obstet; 2014 Feb; 124(2):164-8. PubMed ID: 24268354 [TBL] [Abstract][Full Text] [Related]
4. Drug Seller Provision Practices and Knowledge of Misoprostol in Bangladesh. Reiss K; Keenan K; Church K; Dijkerman S; Mitu SA; Nuremowla S; Ngo TD Int Perspect Sex Reprod Health; 2019 Oct; 45():45-54. PubMed ID: 31639080 [TBL] [Abstract][Full Text] [Related]
5. Medical abortion drug dispensing practices among private pharmacy workers in Nepal: A mystery client study. Sigdel A; Angdembe MR; Khanal P; Adhikari N; Maharjan A; Paudel M PLoS One; 2022; 17(11):e0278132. PubMed ID: 36417473 [TBL] [Abstract][Full Text] [Related]
6. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation. Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260 [TBL] [Abstract][Full Text] [Related]
7. Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives. Crouthamel B; Pearson E; Tilford S; Hurst S; Paul D; Aqtar F; Silverman J; Averbach S Reprod Health; 2021 Mar; 18(1):69. PubMed ID: 33766050 [TBL] [Abstract][Full Text] [Related]
8. Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion. Tamang A; Puri M; Lama K; Shrestha P Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):104-15. PubMed ID: 25702074 [TBL] [Abstract][Full Text] [Related]
9. Pharmacy workers' knowledge and provision of medication for termination of pregnancy in Kenya. Reiss K; Footman K; Akora V; Liambila W; Ngo TD J Fam Plann Reprod Health Care; 2016 Jul; 42(3):208-12. PubMed ID: 26869694 [TBL] [Abstract][Full Text] [Related]
10. Client-pharmacy worker interactions regarding medical abortion in Zambia in 2009 and 2011. Hendrickson C; Fetters T; Mupeta S; Vwallika B; Djemo P; Raisanen K Int J Gynaecol Obstet; 2016 Feb; 132(2):214-8. PubMed ID: 26604158 [TBL] [Abstract][Full Text] [Related]
11. Pharmacy worker practices related to use of misoprostol for abortion in one Mexican state. Billings DL; Walker D; Mainero del Paso G; Clark KA; Dayananda I Contraception; 2009 Jun; 79(6):445-51. PubMed ID: 19442780 [TBL] [Abstract][Full Text] [Related]
12. Using a Call Center to Reduce Harm From Self-Administration of Reproductive Health Medicines in Bangladesh: Interrupted Time-Series. Keenan K; Footman K; Sadekin M; Reiss K; Yasmin R; Franklin H; Church K JMIR Public Health Surveill; 2019 Aug; 5(3):e12233. PubMed ID: 31418425 [TBL] [Abstract][Full Text] [Related]
13. Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh. Alam A; Bracken H; Johnston HB; Raghavan S; Islam N; Winikoff B; Reichenbach L Int Perspect Sex Reprod Health; 2013 Jun; 39(2):79-87. PubMed ID: 23895884 [TBL] [Abstract][Full Text] [Related]
14. Mifepristone-misoprostol for menstrual regulation in public sector facilities in Bangladesh. Alam A; Lotarevich T; Das TR; Reichenbach L; Bracken H Int J Gynaecol Obstet; 2018 Feb; 140(2):205-210. PubMed ID: 29049861 [TBL] [Abstract][Full Text] [Related]
15. Pharmacy Provision of Medication Abortion in Nepal: Pharmacy Owner and Worker Perspectives. Samari G; Puri M; Cohen R; Blum M; Rocca CH Int Perspect Sex Reprod Health; 2018 Sep; 44(3):81-89. PubMed ID: 30698524 [TBL] [Abstract][Full Text] [Related]
16. Pharmacy provision of medical abortifacients in a Latin American city. Lara D; Abuabara K; Grossman D; Díaz-Olavarrieta C Contraception; 2006 Nov; 74(5):394-9. PubMed ID: 17046381 [TBL] [Abstract][Full Text] [Related]
17. Stocking and over-the-counter sale of misoprostol for medical abortion in Ghana's community pharmacies: comparison of questionnaire and mystery client survey. Ganle JK; Busia NT; Baatiema L Int J Pharm Pract; 2020 Jun; 28(3):267-274. PubMed ID: 31746501 [TBL] [Abstract][Full Text] [Related]
18. Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study. Reiss K; Footman K; Burke E; Diop N; Ndao R; Mane B; van Min M; Ngo TD BMC Pregnancy Childbirth; 2017 Jul; 17(1):211. PubMed ID: 28673342 [TBL] [Abstract][Full Text] [Related]
19. Women's experiences with medication for menstrual regulation in Bangladesh. Marlow HM; Biswas K; Griffin R; Menzel J Cult Health Sex; 2016; 18(3):349-60. PubMed ID: 26529099 [TBL] [Abstract][Full Text] [Related]
20. Menstrual regulation in Bangladesh: an evaluation of training and service programs. Amin R; Kamal GM; Mariam AG Int J Gynaecol Obstet; 1988 Oct; 27(2):265-71. PubMed ID: 2903095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]